Brewin Dolphin Wealth Management’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$64K Hold
500
0.01% 175
2022
Q1
$68K Hold
500
0.01% 180
2021
Q4
$70K Hold
500
0.01% 174
2021
Q3
$63.6K Hold
500
0.01% 179
2021
Q2
$63K Hold
500
0.01% 174
2021
Q1
$58.4K Hold
500
0.01% 166
2020
Q4
$56.7K Hold
500
0.01% 157
2020
Q3
$52.7K Hold
500
0.01% 158
2020
Q2
$50K Hold
500
0.01% 155
2020
Q1
$44.3K Hold
500
0.02% 113
2019
Q4
$50.9K Buy
+500
New +$48.1K 0.02% 116
2019
Q3
Sell
-826
Closed -$76.5K 200
2019
Q2
$76.5K Buy
+826
New +$74.3K 0.04% 100

Other funds holding XLV

Brewin Dolphin Wealth Management's XLV Position: Q2 2022 in Review

Brewin Dolphin Wealth Management held its State Street Health Care Select Sector SPDR ETF (XLV) position steady in Q2 2022 at 500 shares worth $64K. The position accounts for 0.01% of the portfolio, ranked #175.

Brewin Dolphin Wealth Management first reported a position in XLV in Q2 2019 and has held it in 12 quarters since. The position peaked at $76.5K in Q2 2019. 1,463 funds tracked by Wall St. Rank hold XLV as of Q2 2022.

  • Brewin Dolphin Wealth Management held 500 shares of State Street Health Care Select Sector SPDR ETF worth $64K as of Q2 2022.
  • Brewin Dolphin Wealth Management left its State Street Health Care Select Sector SPDR ETF share count unchanged in Q2 2022.
  • State Street Health Care Select Sector SPDR ETF made up 0.01% of Brewin Dolphin Wealth Management's portfolio in Q2 2022, its #175 holding.
  • Brewin Dolphin Wealth Management first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2019 and has held it in 12 quarters since.
  • Brewin Dolphin Wealth Management's State Street Health Care Select Sector SPDR ETF position peaked at $76.5K in Q2 2019.
  • 1,463 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2022.

Based on Brewin Dolphin Wealth Management's 13F filing for Q2 2022, filed 14 Nov 2022.